6 - 亚里尔异印-1-单元:新型mGluR2 负基调节剂
1Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Road, Atlanta, Georgia 30322, United State.
研究人员开发了新的化合物,即6 - 烯异印-1-衍生物,它们对甲基酸盐受体2 (mGluR2) 起负基调制剂 (NAM) 的作用. 这项研究详细介绍了它们的合成,并评估了它们对mGluR2和mGluR3.3的功效.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 甲基酸盐受体2 (mGluR2) 是神经系统疾病的关键标.
- 与orthosteric连接剂相比,Allosteric调节剂具有更大的选择性和更好的副作用概况.
- 开发mGluR2的选择性调节剂仍然是药物发现的持续挑战.
研究的目的:
- 为了合成和描述新型的6 - 烯异因多林-1-衍生物.
- 为了评估这些化合物作为转基因谷氨酸受体2 (mGluR2) 的负基调制剂 (NAM).
- 评估这些衍生品对mGluR2和mGluR3.3的选择性和强度.
主要方法:
- 6 - 亚利伊索因多林-1-衍生物的多步化学合成.
- 在体外药理学测试以确定抑制度50% (IC50) 值.
- 放射性配体结合测试和功能测试以确认全调节.
主要成果:
- 一系列新的6 - 烯异印丁-1-衍生物被成功合成.
- 几种化合物证明了mGluR2.2的强烈负度调节.
- 获得了针对mGluR2和密切相关的mGluR3的强度数据 (IC50),提供了初始选择性信息.
结论:
- 新型的6 - 烯异印-1-一基架构代表了开发mGluR2 NAMs的有前途的起点.
- 这些化合物可以作为进一步研究mGluR2在中枢神经系统功能中的作用的宝贵工具.
- 进一步优化可能会导致潜在的治疗药物通过mGluR2活性调节的条件.
更多相关视频
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Antipsychotic Drugs: Typical and Atypical Agents
Allosteric Regulation
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
